Analysis of neuromuscular junctions and effects of anabolic steroid administration in the SOD1G93A mouse model of ALS

Molecular and Cellular Neuroscience

Volumn 51, Issue 1-2, 2012, Pages 12-21

  Cappello, Valentina ^a,b,e   Vezzoli, Elena ^a,b   Righi, Marco ^a,b   Fossati, Matteo ^a,b   Mariotti, Raffaella ^c   Crespi, Arianna ^a,b   Patruno, Marco ^d   Bentivoglio, Marina ^c   Pietrini, Grazia ^a,b   Francolini, Maura ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e CENTER FOR NANOTECHNOLOGY INNOVATION NEST   (Italy)

Author keywords

ALS; Diaphragm; Nandrolone; Neuromuscular junction; SOD1G93A mice; Ultrastructure

Indexed keywords

NANDROLON VETRANAL; NANDROLONE; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DRUG EFFECT; GASTROCNEMIUS MUSCLE; MALE; MOUSE; MUSCLE DENERVATION; MUSCLE MITOCHONDRION; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

AMYOTROPHIC LATERAL SCLEROSIS; ANABOLIC AGENTS; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MICE, TRANSGENIC; MITOCHONDRIA; MUSCLE FIBERS, SKELETAL; MUTATION; NANDROLONE; NEUROMUSCULAR JUNCTION; PRESYNAPTIC TERMINALS; SUPEROXIDE DISMUTASE; SYNAPTIC VESICLES;

MURINAE; MUS;

EID: 84864777689     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2012.07.003     Document Type: Article

References (60)

1. Adachi M., Takayanagi R. Effect of anabolic steroids on osteoporosis. Clin. Calcium 2008, 18(10):1451-1459.
2. Bendotti C., Calvaresi N., Chiveri L., Prelle A., Moggio M., Braga M., Silani V., De Biasi S. Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity. J. Neurol. Sci. 2001, 191(1-2):25-33.
3. Bendotti C., Marino M., Cheroni C., Fontana E., Crippa V., Poletti A., De Biasi S. Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: implication for protein aggregation and immune response. Prog. Neurobiol. 2012, 97(2):101-126.
4. Bergemalm D., Jonsson P.A., Graffmo K.S., Andersen P.M., Brannstorm T., Rehnmark A., Marklund S.L. Overload of stable and exclusion of unstable human superoxide dismutase-1 variants in mitochondria of murine amyotrophic lateral sclerosis models. J. Neurosci. 2006, 26(16):4147-4154.
5. Bisschop A., Gayan-Ramirez G., Rollier H., Dekhuijzen P.N., Dom R., de Bock V., Decramer M. Effects of nandrolone decanoate on respiratory and peripheral muscles in male and female rats. J. Appl. Physiol. 1997, 82(4):1112-1118.
6. Blanco C.E., Zhan W.Z., Fang Y.H., Sieck G.C. Exogenous testosterone treatment decreases diaphragm neuromuscular transmission failure in male rats. J. Appl. Physio. 2001, 90:850-856.
7. Chung M.J., Suh Y.L. Ultrastructural changes of mitochondria in the skeletal muscle of patients with amyotrophic lateral sclerosis. Ultrastruct. Pathol. 2002, 26(1):3-7.
8. Dadon-Nachum M., Melamed E., Offen D. The "dying-back" phenomenon of motor neurons in ALS. J. Mol. Neurosci. 2011, 43(3):470-477.
9. Dejesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.Y., Karydas A., Seeley W.W., Josephs K.A., Coppola G., Geschwind D.H., Wszolek Z.K., Feldman H., Knopman D.S., Petersen R.C., Miller B.L., Dickson D.W., Boylan K.B., Graff-Radford N.R., Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72(2):245-256.
10. Dobrowolny G., Giacinti C., Pelosi L., Nicoletti C., Winn N., Barberi L., Molinaro M., Rosenthal N., Musarò A. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J. Cell. Biol. 2005, 168(2):193-199.
11. Dobrowolny G., Aucello M., Rizzuto E., Beccafico S., Mammucari C., Boncompagni S., Belia S., Wannenes F., Nicoletti C., Del Prete Z., Rosenthal N., Molinaro M., Protasi F., Fanò G., Sandri M., Musarò A. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell. Metab. 2008, 8(5):425-436.
12. Duffy L.M., Chapman A.L., Shaw P.J., Grierson A.J. Review: the role of mitochondria in the pathogenesis of amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 2011, 37(4):336-352.
13. Dupuis L., Loeffler J.P. Neuromuscular junction destruction during amyotrophic lateral sclerosis: insight from transgenic models. Curr Op Pharmacol. 2009, 9:341-348.
14. Ferraiuolo L., Kirby J., Grierson A.J., Sendtner M., Shaw P.J. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol. 2011, 7(11):616-630.
15. Ferri A., Cozzolino M., Crosio C., Nencini M., Casciati A., Gralla E.B., Rotilio G., Valentine J.S., Carrì M.T. Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(37):13860-13865.
16. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 2004, 185(2):232-240.
17. Francolini M., Brunelli G., Cambianica I., Barlati S., Barbon A., La Via L., Guarneri B., Boroni F., Lanzillotta A., Baiguera C., Ettorre M., Buffelli M., Spano P., Clementi F., Pizzi M. Glutamatergic reinnervation and assembly of glutamatergic synapses in adult rat skeletal muscle occurs at cholinergic endplates. J. Neuropathol. Exp. Neurol. 2009, 68(10):1103-1115.
18. Frey D., Schneider C., Xu L., Borg J., Spooren W., Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 2000, 20(7):2534-2542.
19. Gayan-Ramirez G., Rollier H., Vanderhoydonc F., Verhoeven G., Gosselink R., Decramer M. Nandrolone decanoate does not enhance training effects but increases IGF-I mRNA in rat diaphragm. J. Appl. Physiol. 2000, 88(1):26-34.
20. Gould T.W., Buss R.R., Vinsant S., Prevette D., Sun W., Knudson C.M., Milligan C.E., Oppenheim R.W. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J. Neurosci. 2006, 26(34):8774-8786.
21. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994, 264(5166):1772-1775.
22. Hegedus J., Putman C.T., Gordon T. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2007, 28(2):154-164.
23. Hegedus J., Putman C.T., Tyreman N., Gordon T. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J. Physiol. 2008, 586(14):3337-3351.
24. Hemmersbach P., Grosse J. Nandrolone: a multi-faceted doping agent. Handb. Exp. Pharmacol. 2010, 195:127-154.
25. Holzbaur E.L., Howland D.S., Weber N., Wallace K., She Y., Kwak S., Tchistiakova L.A., Murphy E., Hinson J., Karim R., Tan X.Y., Kelley P., McGill K.C., Williams G., Hobbs C., Doherty P., Zaleska M.M., Pangalos M.N., Walsh F.S. Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis. Neurobiol. Dis. 2006, 23(6):697-707.
26. Ilieva H., Polymenidou M., Cleveland D.W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell. Biol. 2009, 187(6):761-772.
27. Jaarsma D., Teuling E., Haasdijk E.D., De Zeeuw C.I., Hoogenraad C.C. Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice. J. Neurosci. 2008, 28(9):2075-2088.
28. Kaspar B.K., Frost L.M., Christian L., Umapathi P., Gage F.H. Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Ann. Neurol. 2005, 57(5):649-655.
29. Kassa R.M., Mariotti R., Bonaconsa M., Bertini G., Bentivoglio M. Gene, cell, and axon changes in the familial amyotrophic lateral sclerosis mouse sensorimotor cortex. J. Neuropathol. Exp. Neurol. 2009, 68(1):59-72.
30. Kong J., Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 1998, 18(9):3241-3250.
31. Kong L., Wang X., Choe D.W., Polley M., Burnett B.G., Bosch-Marcé M., Griffin J.W., Rich M.M., Sumner C.J. Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J. Neurosci. 2009, 29(3):842-851.
32. Lepore A.C., Tolmie C., O'Donnell J., Wright M.C., Dejea C., Rauck B., Hoke A., Ignagni A.R., Onders R.P., Maragakis N.J. Peripheral hyperstimulation alters site of disease onset and course in SOD1 rats. Neurobiol. Dis. 2010, 39(3):252-264.
33. Lewis M.I., Fournier M., Yeh A.Y., Micevych P.E., Sieck G.C. Alterations in diaphragm contractility after nandrolone administration: an analysis of potential mechanisms. J. Appl. Physiol. 1999, 86(3):985-992.
34. Lewis M.I., Horvitz G.D., Clemmons D.R., Fournier M. Role of IGF-I and IGF-binding proteins within diaphragm muscle in modulating the effects of nandrolone. Am. J. Physiol. Endocrinol. Metab. 2002, 282(2):E483-E490.
35. Liu J., Lillo C., Jonsson P.A., Vande Velde C., Ward C.M., Miller T.M., Subramaniam J.R., Rothstein J.D., Marklund S., Andersen P.M., Brännström T., Gredal O., Wong P.C., Williams D.S., Cleveland D.W. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 2004, 43(1):5-17.
36. Lladó J., Haenggeli C., Pardo A., Wong V., Benson L., Coccia C., Rothstein J.D., Shefner J.M., Maragakis N.J. Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS. Neurobiol. Dis. 2006, 21(1):110-118.
37. Macdonald J.H., Marcora S.M., Jibani M.M., Kumwenda M.J., Ahmed W., Lemmey A.B. Nandrolone decanoate as anabolic therapy in chronic kidney disease: a randomized phase II dose-finding study. Nephron. Clin. Pract. 2007, 106(3):c125-c135.
38. Maravelias C., Dona A., Stefanidou M., Spiliopoulou C. Adverse effects of anabolic steroid in athletes. A constant threat. Toxicol. Lett. 2005, 158(3):167-175.
39. Mattiazzi M., D'Aurelio M., Gajewski C.D., Martushova K., Kiaei M., Beal M.F., Manfredi G. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 2002, 277(33):29626-29633.
40. Medei E., Marocolo M., de Carvalho Rodrigues D., Arantes P.C., Maeda Takiya C., Silva J., Rondinelli E., dos Santos Goldenber R.C., Campos de Carvalho A.C., Nascimento J.H.M. Chronic treatment with anabolic steroids induces ventricular repolarization disturbances: cellular, ionic and molecular mechanism. J. Mol. Cell. Cardiol. 2010, 49:165-175.
41. Menzies F.M., Ince P.G., Shaw P.J. Mitochondrial involvement in amyotrophic lateral sclerosis. Neurochem. Int. 2002, 40(6):543-551.
42. Menzies F.M., Cookson M.R., Taylor R.W., Turnbull D.M., Chrzanowska-Lightowlers Z.M., Dong L., Figlewicz D.A., Shaw P.J. Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. Brain 2002, 125(Pt 7):1522-1533.
43. Monks D.A., O'Bryant E.L., Jordan C.L. Androgen receptor immunoreactivity in skeletal muscle: enrichment at the neuromuscular junction. J. Comp. Neurol. 2004, 473(1):59-72.
44. Palazzolo I., Stack C., Kong L., Musaro A., Adachi H., Katsuno M., Sobue G., Taylor J.P., Sumner C.J., Fischbeck K.H., Pennuto M. Overexpression of IGF-1 in muscles attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron 2009, 63:316-328.
45. Pasinelli P., Belford M.E., Lennon N., Bacskai B.J., Hyman B.T., Trotti D., Brown R.H. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 2004, 43(1):19-30.
46. Pinto S., Geraldes R., Vaz N., Pinto A., de Carvalho M. Changes of the phrenic nerve motor response in amyotrophic lateral sclerosis: longitudinal study. Clin. Neurophysiol. 2009, 120(12):2082-2085.
47. Pun S., Santos A.F., Saxena S., Xu L., Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 2006, 9(3):408-419.
48. Qin W., Pan J., Bauman W.A., Cardozo C.P. Differential alterations in gene expression profiles contribute to time-dependent effects of nandrolone to prevent denervation atrophy. BMC Genomics 2010, 11:596-612.
49. Raimondi A., Mangolini A., Rizzardini M., Tartari S., Massari S., Bendotti C., Francolini M., Borgese N., Cantoni L., Pietrini G. Cell culture models to investigate the selective vulnerability of motoneuronal mitochondria to familial ALS-linked G93ASOD1. Eur. J. Neurosci. 2006, 24(2):387-399.
50. Renton A.E., Majounie E., Waite A., Simón-Sánchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., Kalimo H., Paetau A., Abramzon Y., Remes A.M., Kaganovich A., Scholz S.W., Duckworth J., Ding J., Harmer D.W., Hernandez D.G., Johnson J.O., Mok K., Ryten M., Trabzuni D., Guerreiro R.J., Orrell R.W., Neal J., Murray A., Pearson J., Jansen I.E., Sondervan D., Seelaar H., Blake D., Young K., Halliwell N., Callister J.B., Toulson G., Richardson A., Gerhard A., Snowden J., Mann D., Neary D., Nalls M.A., Peuralinna T., Jansson L., Isoviita V.M., Kaivorinne A.L., Hölttä-Vuori M., Ikonen E., Sulkava R., Benatar M., Wuu J., Chiò A., Restagno G., Borghero G., Sabatelli M., The ITALSGEN Consortium, Heckerman D., Rogaeva E., Zinman L., Rothstein J.D., Sendtner M., Drepper C., Eichler E.E., Alkan C., Abdullaev Z., Pack S.D., Dutra A., Pak E., Hardy J., Singleton A., Williams N.M., Heutink P., Pickering-Brown S., Morris H.R., Tienari P.J., Traynor B.J. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72(2):257-268.
51. Righi M., Giacomini A., Lavazza C., Sia D., Carlo-Stella C., Gianni A.M. A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments. Lab. Invest. 2009, 89(9):1063-1070.
52. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S.M., Berger R., Tanzi R.E., Halperin J.J., Herzfeldt B., Van den Bergh R., Hung W.Y., Bird T., Deng G., Mulder D.W., Smyth C., Laing N.G., Soriano E., Pericak-Vance M.A., Haines J., Rouleau G.A., Gusella J.S., Horvitz H.R., Brown R.H. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362(6435):59-62.
53. Sardar P., Jha A., Roy D., Majumdar U., Guha P., Roy S., Banerjee R., Banerjee A.K., Bandyopadhyay D. Therapeutic effects of nandrolone and testosterone in adult male HIV patients with AIDS wasting syndrome (AWS): a randomized, double-blind, placebo-controlled trial. HIV. Clin. Trials. 2010, 11(4):220-229.
54. Schmalbruch H., Lewis D.M. A comparison of the morphology of denervated with aneurally regenerated soleus muscle of rat. J. Muscle. Res. Cell Motil. 1994, 15(3):256-266.
55. Shokri S., Aitken R.J., Abdolvahhabi M., Abolhasani F., Ghasemi F.M., Kashani I., Ejtemaeimehr S., Ahmadian S., Minaei B., Naraghi M.A., Barbarestani M. Exercise and supraphysiological dose of nandrolone decanoate increase apoptosis in spermatogenic cells. Basic Clin. Pharmacol. Toxicol. 2009, 106:324-330.
56. Siklos L., Engelhardt J., Harati Y., Smith R.G., Joo F., Appel S.H. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophic lateral sclerosis. Ann. Neurol. 1996, 39(2):203-216.
57. Toniolo L., Maccatrozzo L., Patruno M., Pavan E., Caliaro F., Rossi R., Rinaldi C., Canepari M., Reggiani C., Mascarello F. Fiber types in canine muscle: myosin isoform expression and functional characterization. Am. J. Physiol. Cell. Physiol. 2007, 292:C1915-C1926.
58. Turner B.J., Talbot K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog. Neurobiol. 2008, 85(1):94-134.
59. Wong M., Martin L.J. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum. Mol. Genet. 2010, 19(11):2284-2302.
60. Zhao J., Zhang Y., Zhao W., Wu Y., Pan J., Bauman W.A., Cardozo C. Effects of nandrolone on denervation atrophy depend upon time after nerve transection. Muscle Nerve 2008, 37(1):42-49.